F19ANALYSIS OF BDNF VAL66MET VARIANT AND EXON IV PROMOTER METHYLATION IN AUTISM SPECTRUM DISORDER TRIOS

Simple item page
dc.contributor.authorSilvia González-Nieves
dc.contributor.authorAndrea López
dc.contributor.authorRoberto Chaskel
dc.contributor.authorClaudia Lattig
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:19:33Z
dc.date.available2026-03-22T16:19:33Z
dc.date.issued2019
dc.descriptionCitaciones: 1
dc.identifier.doi10.1016/j.euroneuro.2018.08.099
dc.identifier.urihttps://doi.org/10.1016/j.euroneuro.2018.08.099
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/57573
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.sourceUniversidad de Los Andes
dc.subjectAllele
dc.subjectHeroin
dc.subjectHaplotype
dc.subjectAddiction
dc.subjectMethadone
dc.subjectGenotype
dc.subjectGenetics
dc.subjectMedicine
dc.subjectAutism spectrum disorder
dc.subjectSingle-nucleotide polymorphism
dc.titleF19ANALYSIS OF BDNF VAL66MET VARIANT AND EXON IV PROMOTER METHYLATION IN AUTISM SPECTRUM DISORDER TRIOS
dc.typearticle

Files

Collections

Artículo Científico Publicado